MeDiNova’s principal aim is to deliver quality clinical trials data on time at its investigator sites. We have developed high quality standards and standard operating procedures (SOPs), which are strictly adhered to.
We undertake internal audits and are regularly visited by monitors from sponsors and CROs who are satisfied with our procedures.
As MeDiNova are large recruiters of patients, we are regularly inspected as part of the Sponsors’ Medicines and Healthcare products Regulatory Agency (MHRA) audits. MeDiNova is approved by the Local Research Ethics Committee (LREC) and Multicentre Research Ethics Committee (MREC) authorities to undertake research studies.
We consider it vital to work with clear SOPs. This ensures that the quality of our clinical research is consistently high and delivered in the same manner by all our team. Our teams adhere to the SOPs and robust, regular training is undertaken by all.